Fred Alger Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,583
Closed -$364K 475
2025
Q4
$364K Sell
3,583
-559,709
-99% -$44.9M ﹤0.01% 410
2025
Q3
$30.8M Buy
+563,292
New +$28.1M 0.12% 91
2024
Q4
Sell
-30,536
Closed -$2.08M 432
2024
Q3
$2.08M Buy
+30,536
New +$1.72M 0.01% 323
2024
Q2
Sell
-8,654
Closed -$598K 443
2024
Q1
$598K Sell
8,654
-95,628
-92% -$6.05M ﹤0.01% 389
2023
Q4
$7.71M Buy
104,282
+47,263
+83% +$3.1M 0.04% 204
2023
Q3
$3.89M Sell
57,019
-53,405
-48% -$4.53M 0.02% 269
2023
Q2
$10.4M Buy
110,424
+80,848
+273% +$6.31M 0.05% 192
2023
Q1
$2.01M Buy
+29,576
New +$1.9M 0.01% 347
2021
Q3
Sell
-30,616
Closed -$3.81M 530
2021
Q2
$3.81M Sell
30,616
-162,480
-84% -$19.4M 0.01% 319
2021
Q1
$25.4M Sell
193,096
-6,155
-3% -$843K 0.07% 194
2020
Q4
$26.4M Buy
199,251
+125,083
+169% +$15.1M 0.07% 181
2020
Q3
$7.56M Buy
74,168
+16,116
+28% +$1.39M 0.02% 218
2020
Q2
$5.05M Buy
58,052
+5,833
+11% +$466K 0.02% 229
2020
Q1
$3.03M Sell
52,219
-7,835
-13% -$636K 0.01% 247
2019
Q4
$5.55M Sell
60,054
-624,641
-91% -$54.9M 0.02% 224
2019
Q3
$61.9M Sell
684,695
-9,434
-1% -$1.07M 0.24% 102
2019
Q2
$81.9M Sell
694,129
-4,975
-0.7% -$501K 0.31% 84
2019
Q1
$60.6M Sell
699,104
-60,710
-8% -$5.17M 0.24% 94
2018
Q4
$47.9M Sell
759,814
-80,011
-10% -$5.49M 0.22% 100
2018
Q3
$66.3M Sell
839,825
-510,821
-38% -$33.3M 0.25% 90
2018
Q2
$80.8M Sell
1,350,646
-1,494,242
-53% -$80.4M 0.34% 59
2018
Q1
$115M Buy
2,844,888
+1,076,357
+61% +$52.5M 0.53% 43
2017
Q4
$92.9M Sell
1,768,531
-291,871
-14% -$15.6M 0.42% 58
2017
Q3
$97.1M Sell
2,060,402
-319,508
-13% -$12.9M 0.45% 54
2017
Q2
$84.2M Buy
+2,379,910
New +$73.5M 0.4% 65

Other funds holding EXAS

Fred Alger Management's EXAS Position: Q1 2026 in Review

Fred Alger Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,583 shares — an estimated $364K sold.

Fred Alger Management first reported a position in EXAS in Q2 2017 and held it in 25 quarters. The position peaked at $115M in Q1 2018. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Fred Alger Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Fred Alger Management sold 3,583 Exact Sciences shares in Q1 2026, an estimated $364K.
  • Fred Alger Management first reported a position in Exact Sciences in Q2 2017 and held it in 25 quarters.
  • Fred Alger Management's Exact Sciences position peaked at $115M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.